TickerFactsScreenerDevelopers

Aclaris Therapeutics, Inc. (ACRS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2014: $417.0K2015: $507.0K2016: $232.0K2017: $1.24M2018: $1.36M2019: $1.61M2020: $453.0K2021: $308.0K2022: $605.0K2023: $1.31M2024: $121.0K2025: $111.0K$111.0K
2014Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$111.0K-8.3%
2024$121.0K-90.8%
2023$1.31M+116.4%
2022$605.0K+96.4%
2021$308.0K-32.0%
2020$453.0K-71.9%
2019$1.61M+19.0%
2018$1.36M+9.8%
2017$1.24M+432.3%
2016$232.0K-54.2%
2015$507.0K+21.6%
2014$417.0K—